Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients
Abstract Background Adrenocortical carcinoma (ACC) is a rare malignant endocrine tumour. Due to a high tumour recurrence rate, the post-operative overall survival (OS) and disease-free survival (DFS) of ACCs is limited. Our research aims to identify the role of the epithelial-mesenchymal transition...
Gardado en:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2019-11-01
|
| Series: | BMC Cancer |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s12885-019-6389-3 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|